Sareh Parangi

Beth Israel Deaconess Medical Center

$2,348,007

Attributed

$2,389,162

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $321K · FY2005–20

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$2,389,162 · 3

By mechanism

R01$1,573,015 · 1

K08$651,525 · 1

R03$164,622 · 1

Top collaborators

Soldano Ferrone1 shared

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Carmelo Nucera$4,177,998
Raghu Kalluri$29,360,132
Francine K Welty$7,046,001
John G Flanagan$19,581,322
Eliyahu Khankin$703,499

Others in their field

Top investigators on “Cell Line”

David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
Dennis R. Burton · Scripps Research Institute$203,685,614
Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
John M Lachin · George Washington University$118,672,444
David M Nathan · Massachusetts Institute Of Technology$118,672,444
Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056

Research focus

Cell LineCellsCancer Cell LineMalignant Neoplasm Of ThyroidInhibitor/AntagonistMalignant NeoplasmsIn VivoIn VitroPathway InteractionsAngiogenesis InhibitorsDistantBcl2 Gene /ProteinDiagnosticDisease ProgressionDetectionDiagnosisFigs - DietaryEndocrineCancer PatientCancer DiagnosisCancer RecurrenceAvidityCell Adhesion MoleculesEfficacy Testing